Home  Research Report 2004

Centre for Biotechnology and Biomedicine (BBZ)

Research Activities at the Centre

Research Reports of the Subcentres

Research Reports of Preceding Years

Search in all Research Reports

Contact

Research Activities at the Centre

The BBZ (Center for Biotechnology and Biomedicine) has been established at Universität Leipzig under the Saxon Biotechnology Offensive as one of two Bioinnovation Centers in Saxony. Funding of about €19 million has been granted for a period of five years (2001-2005) and was realized by the University Scientific Programme and the European Regional Development Fund. As of 2006, the BBZ will be involved in the Universität Leipzig's budget.

BBZ is a central research department at Universität Leipzig. By focusing on the key issues of protein engineering and bioanalytics, molecular medicine and therapeutics, biomedical and cell engineering the university is aiming to combine the expertise of existing research groups with new chairs. The establishment of junior research groups serves the same purpose. The services of an independent management office integrated within the university administration enables research funds to be used effectively.

At BBZ, existing biotechnology university research groups cooperate with new complementary research fields and also with research institutions in biomedicine and biotechnology. In addition, close cooperation takes place between scientific and commercial institutions through the integration of new and established biotechnology companies.

BBZ's mission is:

  • To promote R&D in biotechnology, biomedicine and related disciplines
  • To initiate new degree courses and new types of in-service and further training
  • To facilitate the transfer of findings to economic activities

Chairs at the BBZ

  • Bioanalytics
  • Molecular Biological-Biochemical Processing Technology
  • Molecular Pathogenesis
  • Molecular Cell Therapy
  • Structural Analysis of Biopolymers
  • Cell Techniques and Applied Stem Cell Biology

Independent junior research groups at the BBZ

  • Applied Molecular Evolution
  • Molecular Diagnostics - Microarray Techniques
  • Molecular Medicine of Contagious Diseases
  • Protein Engineering
  • Protein-Ligand Interaction by Ion Cyclotron Mass Spectrometry
  • Solid-state NMR Studies of the Structure of Membrane-associated Proteins

The research projects of the Chair of Bioanalytics (Prof. Ralf Hoffmann) have the overall goal to develop new analytical tools to identify posttranslational modifications as well as to characterize proteins for their phosphorylation, hydroxylation, methylation, glycosylation, desamidation and glycation sites. These mostly reversible but partially irreversible modifications alter and thereby regulate both the structural and functional characteristics of proteins in response to cellular or extracellular signals. Currently we analyze the tau protein, which is a heavily modified brain specific protein and proposed to carry one or several modifications peculiar to Alzheimer's disease (PHF-Tau). Despite world wide research efforts for several decades, the cause of Alzheimer's disease as well its link to Tau and its medications is still unclear. Our work aims to identify novel posttranslational modifications as well as to characterize the phosphoraylation pattern of Tau, which longest human isoform consists of 441 amino acids. For its purification we have developed three chromatographic separations that rely on different protein interactions to the stationary phase, which most importantly do neither discriminate the splicing forms nor posttranslational variants. The purified Tau was quantified relative to each other, their phosphorylation degree was estimated and the distribution of several known phosphorylation sites in the different Tau versions was investigated. Furthermore, we could find a new modification that had not been described for Tau before, which could regulate the Tau-tubulin interaction as well as Tau aggregation. To analyze hydroxyllated amino acids in collagen types, such as hydroxylysine and four hydroxyproline isomers, we have developed two chromatographic methods that are also suitable for quantification. These methods were used to characterize the acid soluble collagen types VI and VIII for their hydroxyamino acids. Together with a research group from the United States we identified a new methyl transferase and characterized this enzyme for its methylation specificity of the guanidino group of arginine residues in proteins. Recently, we have established solid phase synthesis of glycated peptides. The synthesized model peptides will be used to develop the analytical tools to characterize glycated proteins as well as advanced glycation end products (AGEs).

The Chair of Molecular Biological-biochemical Processing Technology (Prof. Andrea A. Robitzki) has enlarged the research and developmental focal points in molecular tissue engineering as well as in drug discovery and functional protein characterisation using cell and tissue based multi-electrode arrays by two further research areas like nanobiotechnology / nanoelectronics and laser directed manipulation and catapulting of viable biological systems. One height was e.g. the successful development and proof in principle of a functional autoimmune antibody-biosensor as a prediagnostic module of preeclampsia (EPH gestosis) during pregnancy. The principle of this cardiomyocyte based multielectrode array is the online and real time monitoring of the contraction rate and arrhythmia by a multielectrode configuration on an array. The frequency of the motility of the cardiomyocyte model represents a functional monitoring of physiological AT1 receptor agonists (detection limit 10-11M) as well as AT1 autoimmune antibodies in sera. Moreover these electronic bioassays can be applied for an enlarged clinical diagnosis, for biomedical and biotechnological research e.g. the detection of cellular events mediated by ligand-receptor interactions. For the development of further cell and tissue based microarrays (impedance spectroscopy) ischemic 2D/3D in vitro cardiomyocytes and a 3D in vitro mammalian retina have been developed and characterised. Another technology platform combined to sensorics was established for laser manipulation and catapulting of living embryonic neuronal precursor cells. The goal of the technology is the establishment of neuronal regeneration and transplant concepts in the field of remyelinisation of nerves. For optimizing molecular biochips and in the course of a miniaturisation for micro-implants and -prostheses projects were started in the field of molecular transistors and nanostructuring of implant surfaces for controlled drug delivery or release.

The Chair of Molecular Pathogenesis (Prof. Manfred Blessing) investigates the function of growth factors and cytokines. The research is focused on members of the "Transforming Growth Factor-beta" (TGF-beta) family. TGF-beta is a pleiotropic factor. TGF-beta is a central regulator of the immune system promotes proliferation and differentiation of mesenchymal cells but strongly inhibits epithelial cell proliferation and modulates angiogenesis and apoptosis. Because of this broad spectrum of activities which may be quite opposite in different cell types, changes in TGF-beta activity or TGF-beta responsiveness strongly affect tissue homeostasis and tissue function. It is thus not surprising that modifications of the TGF-beta system are found in a variety of diseases including cancer, immune system malfunction and impaired regeneration. For functional analysis we generated a series of transgenic mice with local and cell-type specific modifications in TGF-beta activity or TGF-beta responsiveness. A correlation between these modifications and altered susceptibility towards cancer and immune system malfunction is being established. For example, loss of TGF-beta responsiveness in skin, gut and liver quite differently affected tumor incidence in these tissues and reflected the frequency of respective mutations in tumors of skin, gut and liver from patients. In addition, we demonstrated that loss of TGF-beta responsiveness in T-cells augmented susceptibility towards asthma, hepatitis and arthritis, whereas increased TGF-beta secretion by T-cells rendered resistance towards asthma. At the same time cell-type specific target genes of this central regulator are being identified in these models using high density DNA-chip arrays. From these analyses we expect new candidate genes which due to their cell-type specificity lead to the development of new diagnostic, prognostic and therapeutic tools.

The main research interest of the Chair of Structural Analysis of Biopolymers (Prof. Norbert Sträter) is the study of the relationship between the three-dimensional structure of proteins and their function by using biochemical and biophysical methods, mainly protein crystallography. Here, currently enzymes are being studied, mostly metalloenzymes, but also other proteins of medical or biotechnological relevance. Aside from the study of the structure of the native protein, a prime interest is the characterization of the catalytic mechanism or function of a protein on a molecular basis. Current projects focus on metallohydrolases, pharmacologically relevant extracellular receptor proteins and proteins involved in signal transduction. The place of the group's research is at the interface between chemistry and life sciences: Prominent examples are the analysis of the chemical catalytic mechanisms of enzymes or the molecular mode of action of synthetic drugs on the biological targets by structural analysis of the complex structures.

The research interests of the Chair of Cell Techniques and Applied Stem Cell Biology (Prof. Augustinus Bader) lie within the area of regenerative medicine. One focus of the group's interests is the elucidation of the mechanisms of regeneration following liver damage. Possible non-haematopoietic functions of peptides hitherto considered as primarily haematopoietic have been identified by the group and the investigation of the roles of thrombopoietin (TPO) and erythropoietin (EPO) in liver regeneration have become a particular focus of the group's attention. Application of EPO led to a quantifiable acceleration of liver regeneration following partial hepatectomy in pigs. Currently, the precise nature of the effects of "haematopoietic peptides" on liver regeneration are being investigated in various model systems. Amongst other techniques, we are studying changes in gene expression with our own in-house developed oligo microarrays and investigating both quantitative and qualitative changes in regenerating tissue. The practical aim of our studies is to help to derive therapies which support liver regeneration via the application of regeneration-inducing mediators and extracorporeal liver support.

The research group efforts towards the "development of a bioreactor circuit for sterile chondrocyte stimulation and bioanalytical characterization" had the development of a modular bioreactor system as a major goal. The design and construction of the system surrounding the stimulation chamber, especially the sensory and control components, were identified as being of the utmost importance. Due to the extremely challenging operational requirements, a modular system consisting of individual bioreactor modules, a control unit, a user interface and individual system communications ports was devised.

A single module consists of a bioreactor and associated circuitry with a nutrition reservoir, a supply pump, a flow sensor and a temperature sensor. In addition, a secondary circuit for online analysis including relevant sensors, a dosing pump and a three-way valve for extracting samples for offline analysis is connected to the primary circuit. A secondary reservoir can also be attached to the primary nutrition reservoir. This secondary reservoir can be used to regulate the supply of high value nutritional components such as plasma or serum and can also provide "conditioned" feeding with autologous nutrients in a fed batch mode.

In practise, six cartilage constructs were simultaneously and identically stimulated and cultivated. From six such constructs, one could be destined for clinical implantation, whilst the remainder could be used for biochemical, biophysical and genetic analyses.

The junior research group Applied Molecular Evolution (PD Dr. Susanne Brakmann) is concerned with directed evolution techniques for the functional optimization of nucleic acid polymerases and also, techniques for the realization of single molecule DNA sequencing. The studies on polymerases focus on the development of variants of T7 DNA polymerase and HIV Reverse Transcriptase with altered error rate and on the development of variants of T7 RNA polymerase with altered substrate tolerance. A major advance concerns the development of genetic selection approaches for the identification and isolation of active polymerases from polymerase mutant libraries which are produced e.g. by error-prone PCR or by DNA shuffling. Usually, such libraries contain predominatly inactive variants (more than 90 %). By using certain polymerase-deficient E. coli strains or strains with limited polymerase activity we were able to specifically enrich active polymerase variants that complemented the missing activity. In the case of T7 RNA polymerase, this complementation failed; however, we were able to identify and isolate active variants after transcription (and expression) of a marker protein (GFP). Following the genetic selection, active variants (DNA and RNA polymerases) were then screened for specific substrate tolerances using microplate assays (FRET- and fluorescence detection).

The junior research group Molecular Diagnostics - Microarray Techniques (Dr. Peter Ahnert) analyses interindividual diversity in the etiology and pathogenesis of autoimmune diseases, especially rheumatoid arthritis. Autoimmune diseases like rheumatoid arthritis (RA) are complex diseases with various causative factors. It is well accepted that genetic predisposition plays a role in disease susceptibility and disease progression. Most likely, not just the well known HLA locus is involved. However, to date it is unclear which other genes and their variants may be important. The study of candidate genes and their polymorphisms appears to be a promising approach to elucidate this problem. Likely, combinations or patterns of low penetrance gene variants are important here and for complex diseases in general. This points in the direction of systems biology. The goal of this project is to contribute to the elucidation of the genetic component in the etiology and pathogenesis of RA and to further the development of methods for investigating the genetics of complex diseases in general.

We apply statistical methods to the analysis of biological networks for the selection of candidate genes. SNPs are selected from public databases. For genotyping we use the GENOLINK system which is based on primer extension and mass spectrometry. We apply methods from statistical genetics and machine learning to the analysis of genotype-phenotype associations.

Our research projects are supported by the "Sächsische Aufbaubank", the "HWP", "EFRE" and the "DFG". We work in close collaboration with the group of Dr. Francois Cornélis (University of Evry and University Paris VII), the group of Jose Cardoso de Menezes (Technical University of Lisbon, Portugal) as well as with several partners in Germany.

The scientific interests of the junior research group Molecular Medicine of Infectious Diseases (PD Dr. Reinhard Straubinger) focus on the molecular mechanisms that pertain to infectious diseases caused by spirochetes (Lyme borreliosis, Relapsing fever) in man and animals. In this context, the role of the cytokines Interleukin (IL)-23 and IL-17 in chronic Lyme arthritis was also investigated and modifications of the vaccination strategies against Lyme borreliosis, which may be relevant for clinical use, were evaluated.
During the last months it became evident that two linear plasmids, which are known to be essential for the infectiousness of Borrelia burgdorferi, have no impact on the phagocytosis rate displayed by polymorphonuclear neutrophils (PMNs) and monocytes. This means, that the host's innate immune system is not affected by proteins coded by these plasmids in terms of spirochete internalization. Currently, phagocytosis rates of PMNs and monocytes facing spiral- or spherical-shaped B. burgdorferi organisms are compared. This is of special interest, since spiral-shaped organisms are thought to be important for an active infection with B. burgdorferi, while spherical-shaped spirochetes show reduced metabolic activity and therefore might be the cause for persistent infection. Furthermore, for the first time we succeeded to cultivate an additional borrelia species, Borrelia persica, in vitro. Due to the conspicuous biological differences seen among B. burgdorferi und B. persica - e.g. B. burgdorferi is found in the host's tissue and causes slowly developing clinical signs, while B. persica is predominately found in the blood stream and is the cause of relapsing fever attacks - the direct comparison of both species offers a solid basis to investigate the molecular mechanisms of persistent infection in more detail. Chronic inflammatory responses in joints may result from persistent infections years later. The underlying pathogenic mechanisms are unknown so far. In this context the group investigates the inflammation supporting or even initiating role of IL-23 and IL-17 in the murine animal model. Finally, the impact of a modified immunization regimen on the production of vaccine-induced antibodies in the dog was evaluated quantitatively and qualitatively for five vaccines that are available against Lyme borreliosis in Europe and the USA.

The research field of the junior research group Protein Engineering (Dr. Thomas Greiner-Stöffele) is the application and development of methods for the rational protein design and for in vitro evolution of proteins. Two areas were in the focus of the group. On the one hand the improved stabilization of exonuclease III of E. coli has been continued. For this purpose further rational mutations were introduced into the protein and libraries for the in vitro evolution of this enzyme were generated. Using rational design a new exonuclease variant could be developed, showing an increase in the optimum incubation temperature by 8 °C and allowing a more efficient production and storage of the enzyme. In Cooperation with the group of Prof. Sträter (BBZ) protein crystals could be grown for two thermostable proteins homologous to exonuclease.

On the other hand a procedure for the screening of large libraries of protein variants has been enhanced and an adaptation of the process to new enzyme classes was started. Therefore the recombinant expression and activity assays for various enzymes (restriction endonucleases, aldoketo-reductases, dehydrogenases and dioxygenases) were established. Various libraries were generated for example enzymes of these classes. The screening of these libraries was started.

The junior research group Protein-Ligand Interaction by Ion Cyclotron Resonance Mass Spectrometry (Dr. Andrea Sinz) employed the Fourier transform ion cyclotron resonance (FTICR) mass spectrometry to analyze complex protein mixtures. We succeeded in identifying hundreds of proteins from E. coli cell lysates by combining several chromatographic separation steps with high-resolution FTICR mass spectrometry. The strategy based on liquid chromatography possesses the potential to replace two-dimensional gel electrophoresis, which is currently the predominately employed separation technique in proteomics studies.

We continued our research efforts in improving the strategy to elucidate low-resolution three-dimensional structures of protein complexes by chemical cross-linking and high-resolution mass spectrometry. Highly complex mixtures, as they are created by chemical cross-linking of proteins, are analyzed by nano-HPLC/nano-ESI-FTICR mass spectrometry without further pre-separation steps. In order to facilitate identification of cross-linking products, we employed isotope-labeled cross-linking reagents. Based on the distance constraints between the complex constituting components, information on interfaces between the binding partners is obtained. As model systems, we employed two protein complexes between calmodulin and its target peptides melittin and a C-terminal peptide of the skeletal muscle myosin light chain kinase. For the complex between calmodulin and the peptide from the skeletal muscle myosin light chain kinase, the distance constraints were in agreement with the published NMR structure. For the complex between calmodulin and melittin, two structural models were created based on the distance constraints obtained by chemical cross-linking.

Further applications of the strategy to map protein interfaces by chemical cross-linking and high-resolution FTICR mass spectrometry currently consist in the identification of interacting regions between calmodulin and a C-terminal peptide derived from adenylyl cyclase 8 (cooperation with Prof. Dermot Cooper, Cambridge University, UK) as well as in the analysis of laminin self-aggregation (cooperation with Dr. Neil Smyth, University of Cologne).

The junior research group Solid-state NMR Studies of the Structure of Membrane-associated Proteins (PD Dr. Daniel Huster) has been dealing with the characterization of the structure and dynamics of membrane bound molecules such as the ras protein and the carrier peptide hCT(9-32). One focus of the investigation was the comprehensive application of 2H NMR methods to determine motional amplitudes and correlation times of the motion of the lipid chain modifications of the C-terminus of ras. For hCT(9-32), a structural model of the membrane associated state was built on the basis of the structural parameters determined by solid-state NMR methods.

A second topic of the research was the investigation of natural and tissue engineered cartilage. By means of solid-state NMR spectroscopy, the molecular components of the tissue could be individually detected and their dynamical parameters have been determined. This rational has first been applied to characterize artificial tissue. The goal of this research is the quantitative characterization of the molecular properties of tissue engineered cartilage. Thus, a quality control / quality assurance analysis will be established that allows for the optimization of individual production of autologus cartilage tissue.


 

 

 

Home Zusammenstellung: Forschungskontaktstelle, 12.07.2005